Trial Talks, a clinical trials podcast, focuses on industry trends, patients, and clinical advancements made with the help of innovative technology.
In this episode, we discuss with Kafayat Babajide, Director of Patient Insights & Experience with Johnson and Johnson, the ways in which a patient-centric approach can remove controllable barriers from the clinical trial process.
In this episode, Rose Gerber, Director of Patient Advocacy and Education at the Community Oncology Alliance – once a patient herself and now a dedicated advocate – will share her story.
In this podcast we are joined by Kimberly Richardson, Patient Advocate and Cancer Survivor, to discuss how we can work towards achieving health equity in the United States, what steps can be taken today, and the impact this would have on clinical research.
Our fully integrated RTSM and EDC allows you to spend more time focused on your data and less on outside programmers and vendors. In this episode we will explore the value of a combined solution and what you can expect in return.
Advocating for a human being, not a test subject. As clinical research evolves more emphasis has been placed on patient experience, rather than just data points.
In this podcast we’ll discuss how Clindata succeeded in making the switch from paper to EDC and the benefits of this change for animal health studies.
In this podcast we’ll discuss the need for data visualization in clinical trials, how Phastar has continued their trials during a global pandemic, and what their thoughts are on the future of how we collect and view data.
In this podcast, we’ll discuss the foundation of our successful partnership, eSource, and the innovative ways we are collaborating with Quartesian on a COVID-19 study currently underway.
In this podcast we sit down with Mary Mattes, Senior Vice President of Global Operations at Synteract to discuss decentralization of clinical trials and a hybrid model.
In this podcast, the CEO of Hope Biosciences discusses the recent advances in stem-cell research, the potential stem-cells have for curing disease, and what she believes the future may hold.
In this podcast, Yvonne Lungershausen and Sandrien Louwaars discuss how Avance Clinical prepared for the pandemic, what tools they implemented that allowed trial continuation, and why clinical trials are currently thriving in the region.
This episode will cover dynamic survey design, informed consent, patient diversity, and patient safety as they relate to achieving true patient-centricity in your studies.
Sign up to have our the latest insights delivered to your inbox.
